Funding Rounds
EverImmune

EverImmune Series A (2021, $5M)

EverImmune

Therapeutic tools for treating cancer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $5.71M

Raised Date: 2021-01-01